Drug Type Antibody oligonucleotide conjugates |
Synonyms- |
Target |
Action inhibitors, antagonists |
Mechanism MSTN inhibitors(Growth/differentiation factor 8 inhibitors), TfR1 antagonists(Transferrin receptor protein 1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Dystrophy, Duchenne | Preclinical | - | - |